Fluoro Beta-Carboline Compounds, Bone Formation Method
Summary
USPTO published patent application US20260097041A1 for fluoro beta-carboline compounds and methods of promoting bone formation. The application (No. 19202018, filed May 8, 2025) covers compounds of Formula I and their use in orthopedic devices, periodontal devices, and treatment of renal disease, diabetes, bone loss, and cancer. Inventors include Debra Ellies, F. Scott Kimball, and Robert N. Young.
What changed
USPTO published patent application US20260097041A1 covering fluoro beta-carboline compounds of Formula I and methods for promoting bone formation in subjects. The application also discloses orthopedic and periodontal devices incorporating the compounds, as well as methods for treating renal disease, diabetes, bone loss, and cancer using the disclosed compounds.
For pharmaceutical and medical device companies, this published application signals potential future market exclusivity for bone formation therapeutics and related devices. Competitors developing similar compounds or bone regeneration treatments should review the claims upon issuance and monitor prosecution history for potential licensing or design-around opportunities. Healthcare providers may see future treatment options for bone loss and related conditions based on this technology.
What to do next
- Monitor for patent issuance and prosecution updates
- Review for potential licensing opportunities if developing related compounds
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
FLUORO BETA-CARBOLINE COMPOUNDS
Application US20260097041A1 Kind: A1 Apr 09, 2026
Inventors
Debra ELLIES, F. Scott KIMBALL, Robert N. YOUNG
Abstract
In one aspect, the invention provides compounds of Formula I, and salts, hydrates and isomers thereof. In another aspect, the invention provides a method of promoting bone formation in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of Formula I. The present invention also provides orthopedic and periodontal devices, as well as methods for the treatment of renal disease, diabetes, bone loss, and cancer, using a compound of Formula I.
CPC Classifications
A61K 31/5377 A61K 31/444 A61K 31/496 A61K 31/5386 A61K 31/55 A61K 35/32 A61K 39/3955 A61P 19/10 C07D 471/04 C07D 491/048 C07D 498/08
Filing Date
2025-05-08
Application No.
19202018
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.